KEGG   PATHWAY: fpg04020
Entry
fpg04020                    Pathway                                
Name
Calcium signaling pathway - Falco peregrinus (peregrine falcon)
Description
Ca2+ that enters the cell from the outside is a principal source of signal Ca2+. Entry of Ca2+ is driven by the presence of a large electrochemical gradient across the plasma membrane. Cells use this external source of signal Ca2+ by activating various entry channels with widely different properties. The voltage-operated channels (VOCs) are found in excitable cells and generate the rapid Ca2+ fluxes that control fast cellular processes. There are many other Ca2+-entry channels, such as the receptor-operated channels (ROCs), for example the NMDA (N-methyl-D-aspartate) receptors (NMDARs) that respond to glutamate. There also are second-messenger-operated channels (SMOCs) and store-operated channels (SOCs).
The other principal source of Ca2+ for signalling is the internal stores that are located primarily in the endoplasmic/sarcoplasmic reticulum (ER/SR), in which inositol-1,4,5-trisphosphate receptors (IP3Rs) or ryanodine receptors (RYRs) regulate the release of Ca2+. The principal activator of these channels is Ca2+ itself and this process of Ca2+-induced Ca2+ release is central to the mechanism of Ca2+ signalling. Various second messengers or modulators also control the release of Ca2+. IP3, which is generated by pathways using different isoforms of phospholipase C (PLCbeta, delta, epsilon, gamma and zeta), regulates the IP3Rs. Cyclic ADP-ribose (cADPR) releases Ca2+ via RYRs. Nicotinic acid adenine dinucleotide phosphate (NAADP) may activate a distinct Ca2+ release mechanism on separate acidic Ca2+ stores. Ca2+ release via the NAADP-sensitive mechanism may also feedback onto either RYRs or IP3Rs. cADPR and NAADP are generated by CD38. This enzyme might be sensitive to the cellular metabolism, as ATP and NADH inhibit it.
The influx of Ca2+ from the environment or release from internal stores causes a very rapid and dramatic increase in cytoplasmic calcium concentration, which has been widely exploited for signal transduction. Some proteins, such as troponin C (TnC) involved in muscle contraction, directly bind to and sense Ca2+. However, in other cases Ca2+ is sensed through intermediate calcium sensors such as calmodulin (CALM).
Class
Environmental Information Processing; Signal transduction
Pathway map
fpg04020  Calcium signaling pathway
fpg04020

Other DBs
GO: 0019722
Organism
Falco peregrinus (peregrine falcon) [GN:fpg]
Gene
101910278  HTR4; 5-hydroxytryptamine receptor 4 [KO:K04160]
101910328  PDGFD; platelet derived growth factor D [KO:K05450]
101910447  [KO:K04163]
101910521  EGFR; epidermal growth factor receptor [KO:K04361] [EC:2.7.10.1]
101910546  [KO:K05212]
101910574  [KO:K00907] [EC:2.7.11.18]
101910610  ERBB4; erb-b2 receptor tyrosine kinase 4 [KO:K05085] [EC:2.7.10.1]
101910675  CAMK1G; calcium/calmodulin dependent protein kinase IG [KO:K08794] [EC:2.7.11.17]
101910725  GRIN2C; glutamate ionotropic receptor NMDA type subunit 2C [KO:K05211]
101910788  CAMK1; calcium/calmodulin dependent protein kinase I [KO:K08794] [EC:2.7.11.17]
101910888  CACNG7; protein kinase C gamma type [KO:K19663] [EC:2.7.11.13]
101910912  [KO:K05853] [EC:7.2.2.10]
101911086  GRPR; gastrin releasing peptide receptor [KO:K04169]
101911097  PLCD3; phospholipase C delta 3 [KO:K05857] [EC:3.1.4.11]
101911221  ASPH; aspartate beta-hydroxylase [KO:K00476] [EC:1.14.11.16]
101911506  CHRNA7; cholinergic receptor nicotinic alpha 7 subunit [KO:K04809]
101911510  PLN; phospholamban [KO:K05852]
101911529  ATP2A3; ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 3 [KO:K05853] [EC:7.2.2.10]
101911541  DRD5; dopamine receptor D5 [KO:K05840]
101911646  ITPR3; inositol 1,4,5-trisphosphate receptor type 3 [KO:K04960]
101911647  ADCY2; adenylate cyclase 2 [KO:K08042] [EC:4.6.1.1]
101911763  TNNC2; troponin C2, fast skeletal type [KO:K12042]
101911850  NFATC3; nuclear factor of activated T-cells 3 [KO:K17333]
101911857  TACR2; tachykinin receptor 2 [KO:K04223]
101911936  P2RX5; purinergic receptor P2X 5 [KO:K05219]
101911995  SLC25A5; solute carrier family 25 member 5 [KO:K05863]
101912011  PRKCB; protein kinase C beta [KO:K19662] [EC:2.7.11.13]
101912067  VDAC1; voltage dependent anion channel 1 [KO:K05862]
101912084  VEGFD; vascular endothelial growth factor D [KO:K05449]
101912097  CALML4; calmodulin like 4 [KO:K02183]
101912123  NTRK3; neurotrophic receptor tyrosine kinase 3 [KO:K05101] [EC:2.7.10.1]
101912141  [KO:K13755] [EC:3.1.4.17]
101912221  ORAI1; ORAI calcium release-activated calcium modulator 1 [KO:K16056]
101912258  ADRA1D; adrenoceptor alpha 1D [KO:K04137]
101912278  CD38; CD38 molecule [KO:K01242] [EC:3.2.2.6 2.4.99.20]
101912345  TRDN; triadin [KO:K23449]
101912351  GRIN2A; glutamate ionotropic receptor NMDA type subunit 2A [KO:K05209]
101912382  TFEB; transcription factor EB [KO:K15590]
101912387  P2RX6; purinergic receptor P2X 6 [KO:K05221]
101912415  PLCB2; phospholipase C beta 2 [KO:K05858] [EC:3.1.4.11]
101912447  PLCG1; phospholipase C gamma 1 [KO:K01116] [EC:3.1.4.11]
101912464  GNAQ; guanine nucleotide-binding protein G(q) subunit alpha [KO:K04634]
101912626  VEGFC; vascular endothelial growth factor C [KO:K05449]
101912632  HTR7; 5-hydroxytryptamine receptor 7 [KO:K04163]
101912795  CACNA1D; calcium voltage-gated channel subunit alpha1 D [KO:K04851]
101912862  GRIN2B; glutamate ionotropic receptor NMDA type subunit 2B [KO:K05210]
101913028  PHKA1; phosphorylase kinase regulatory subunit alpha 1 [KO:K07190]
101913094  ATP2A2; ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 [KO:K05853] [EC:7.2.2.10]
101913113  CAMK4; calcium/calmodulin dependent protein kinase IV [KO:K05869] [EC:2.7.11.17]
101913157  [KO:K05840]
101913185  GRIN1; glutamate ionotropic receptor NMDA type subunit 1 [KO:K05208]
101913198  GRIN3B; glutamate ionotropic receptor NMDA type subunit 3B [KO:K05214]
101913216  ADORA2B; adenosine A2b receptor [KO:K04267]
101913304  DRD1; dopamine receptor D1 [KO:K04144]
101913316  [KO:K05096] [EC:2.7.10.1]
101913384  VEGFA; vascular endothelial growth factor A [KO:K05448]
101913442  RYR2; ryanodine receptor 2 [KO:K04962]
101913447  HTR2A; 5-hydroxytryptamine receptor 2A [KO:K04157]
101913531  PDGFRA; platelet derived growth factor receptor alpha [KO:K04363] [EC:2.7.10.1]
101913673  PLCE1; phospholipase C epsilon 1 [KO:K05860] [EC:3.1.4.11]
101913692  FGFR2; fibroblast growth factor receptor 2 [KO:K05093] [EC:2.7.10.1]
101913700  SLC8A3; solute carrier family 8 member A3 [KO:K05849]
101913726  NFATC1; nuclear factor of activated T-cells 1 [KO:K04446]
101913732  TBXA2R; thromboxane A2 receptor [KO:K04264]
101913927  PHKB; phosphorylase kinase regulatory subunit beta [KO:K07190]
101913992  CACNA1I; calcium voltage-gated channel subunit alpha1 I [KO:K04856]
101914068  GNAL; G protein subunit alpha L [KO:K04633]
101914093  FGFR1; fibroblast growth factor receptor 1 [KO:K04362] [EC:2.7.10.1]
101914106  ERBB3; erb-b2 receptor tyrosine kinase 3 [KO:K05084] [EC:2.7.10.1]
101914322  FGF18; fibroblast growth factor 18 [KO:K04358]
101914329  PLCG2; phospholipase C gamma 2 [KO:K05859] [EC:3.1.4.11]
101914383  ERBB2; erb-b2 receptor tyrosine kinase 2 [KO:K05083] [EC:2.7.10.1]
101914389  ATP2B4; ATPase plasma membrane Ca2+ transporting 4 [KO:K05850] [EC:7.2.2.10]
101914397  AGTR1; angiotensin II receptor type 1 [KO:K04166]
101914455  PPP3CA; protein phosphatase 3 catalytic subunit alpha [KO:K04348] [EC:3.1.3.16]
101914550  HRH1; histamine receptor H1 [KO:K04149]
101914593  CAMK2D; calcium/calmodulin dependent protein kinase II delta [KO:K04515] [EC:2.7.11.17]
101914615  ADCY7; adenylate cyclase 7 [KO:K08047] [EC:4.6.1.1]
101914699  PRKCA; protein kinase C alpha [KO:K02677] [EC:2.7.11.13]
101914764  CACNA1S; calcium voltage-gated channel subunit alpha1 S [KO:K04857]
101914769  ADCY1; adenylate cyclase 1 [KO:K08041] [EC:4.6.1.1]
101914885  CAMK1D; calcium/calmodulin dependent protein kinase ID [KO:K08794] [EC:2.7.11.17]
101915028  PDGFC; platelet derived growth factor C [KO:K05450]
101915075  ATP2B2; ATPase plasma membrane Ca2+ transporting 2 [KO:K05850] [EC:7.2.2.10]
101915080  RYR3; ryanodine receptor 3 [KO:K04963]
101915107  FGF3; fibroblast growth factor 3 [KO:K04358]
101915131  CASQ2; calsequestrin 2 [KO:K23445]
101915240  VDAC2; voltage dependent anion channel 2 [KO:K15040]
101915293  NTSR1; neurotensin receptor 1 [KO:K04211]
101915367  CAMK2G; calcium/calmodulin dependent protein kinase II gamma [KO:K04515] [EC:2.7.11.17]
101915493  VDAC3; voltage dependent anion channel 3 [KO:K15041]
101915644  STIM2; stromal interaction molecule 2 [KO:K18196]
101915662  HRH2; histamine receptor H2 [KO:K04150]
101915737  [KO:K04282]
101915830  GRM5; glutamate metabotropic receptor 5 [KO:K04604]
101915836  EDNRB; endothelin receptor type B [KO:K04198]
101915976  CCKAR; cholecystokinin A receptor [KO:K04194]
101916006  FGF17; fibroblast growth factor 17 [KO:K04358]
101916173  HTR2C; 5-hydroxytryptamine receptor 2C [KO:K04157]
101916268  FGF20; fibroblast growth factor 20 [KO:K04358]
101916606  ITPR1; inositol 1,4,5-trisphosphate receptor type 1 [KO:K04958]
101916667  HTR5A; 5-hydroxytryptamine receptor 5A [KO:K04161]
101916694  CACNA1C; voltage-dependent L-type calcium channel subunit alpha-1C [KO:K04850]
101916703  GRIN3A; glutamate ionotropic receptor NMDA type subunit 3A [KO:K05213]
101916711  PLCB4; phospholipase C beta 4 [KO:K05858] [EC:3.1.4.11]
101916747  NOS1; nitric oxide synthase 1 [KO:K13240] [EC:1.14.13.39]
101916818  CALM2; calmodulin 2 [KO:K02183]
101916879  EGF; epidermal growth factor [KO:K04357]
101917020  TRHR; thyrotropin releasing hormone receptor [KO:K04282]
101917184  HGF; hepatocyte growth factor [KO:K05460]
101917220  SNRPG; small nuclear ribonucleoprotein polypeptide G [KO:K08774]
101917266  BDKRB2; bradykinin receptor B2 [KO:K03916]
101917348  ADRB1; adrenoceptor beta 1 [KO:K04141]
101917352  [KO:K05869] [EC:2.7.11.17]
101917366  SLC25A6; solute carrier family 25 member 6 [KO:K05863]
101917374  SLC25A4; solute carrier family 25 member 4 [KO:K05863]
101917440  MYLK3; myosin light chain kinase 3 [KO:K00907] [EC:2.7.11.18]
101917444  BDKRB1; bradykinin receptor B1 [KO:K03915]
101917477  P2RX3; purinergic receptor P2X 3 [KO:K05217]
101917478  OXTR; oxytocin receptor [KO:K04229]
101917506  PPP3CC; protein phosphatase 3 catalytic subunit gamma [KO:K04348] [EC:3.1.3.16]
101917626  F2R; coagulation factor II thrombin receptor [KO:K03914]
101917697  CXCR4; C-X-C motif chemokine receptor 4 [KO:K04189]
101917722  FGFR4; fibroblast growth factor receptor 4 [KO:K05095] [EC:2.7.10.1]
101917764  GNA14; guanine nucleotide-binding protein subunit alpha-14 [KO:K04636]
101917881  CACNA1G; calcium voltage-gated channel subunit alpha1 G [KO:K04854]
101917907  TPCN1; two pore segment channel 1 [KO:K16896]
101918084  FLT4; fms related tyrosine kinase 4 [KO:K05097] [EC:2.7.10.1]
101918177  TPCN2; two pore segment channel 2 [KO:K14077]
101918231  ITPKB; inositol-trisphosphate 3-kinase B [KO:K00911] [EC:2.7.1.127]
101918253  FGF2; fibroblast growth factor 2 [KO:K18497]
101918282  [KO:K01116] [EC:3.1.4.11]
101918298  CYSLTR2; cysteinyl leukotriene receptor 2 [KO:K04323]
101918418  EDNRA; endothelin receptor type A [KO:K04197]
101918420  PPIF; peptidylprolyl isomerase F [KO:K09565] [EC:5.2.1.8]
101918438  PDGFRB; platelet derived growth factor receptor beta [KO:K05089] [EC:2.7.10.1]
101918492  NOS3; nitric oxide synthase, endothelial [KO:K13242] [EC:1.14.13.39]
101918536  PPP3CB; protein phosphatase 3 catalytic subunit beta [KO:K04348] [EC:3.1.3.16]
101918615  ADRB3; adrenoceptor beta 3 [KO:K04143]
101918748  FGF16; fibroblast growth factor 16 [KO:K04358]
101918858  NFATC2; nuclear factor of activated T-cells 2 [KO:K17332]
101918953  CAMK2A; calcium/calmodulin dependent protein kinase II alpha [KO:K04515] [EC:2.7.11.17]
101918979  TACR3; tachykinin receptor 3 [KO:K04224]
101919099  CALM1; calmodulin 1 [KO:K02183]
101919147  P2RX4; purinergic receptor P2X 4 [KO:K05218]
101919158  CHRM2; cholinergic receptor muscarinic 2 [KO:K04130]
101919186  CACNA1A; voltage-dependent P/Q-type calcium channel subunit alpha-1A [KO:K04344]
101919188  TNNC1; troponin C1, slow skeletal and cardiac type [KO:K05865]
101919300  [KO:K05840]
101919310  P2RX7; purinergic receptor P2X 7 [KO:K05220]
101919319  NTRK2; neurotrophic receptor tyrosine kinase 2 [KO:K04360] [EC:2.7.10.1]
101919366  HTR2B; 5-hydroxytryptamine receptor 2B [KO:K04157]
101919456  MST1; macrophage stimulating 1 [KO:K23441]
101919536  PTAFR; platelet activating factor receptor [KO:K04279]
101919541  PTK2B; protein tyrosine kinase 2 beta [KO:K05871] [EC:2.7.10.2]
101919616  CYSLTR1; cysteinyl leukotriene receptor 1 [KO:K04322]
101919694  SLC8A2; solute carrier family 8 member A2 [KO:K05849]
101919734  PLCD1; phospholipase C delta 1 [KO:K05857] [EC:3.1.4.11]
101919810  ADRB2; adrenoceptor beta 2 [KO:K04142]
101919998  FGF6; fibroblast growth factor 6 [KO:K04358]
101920035  SLN; sarcolipin [KO:K22642]
101920077  PHKG1; phosphorylase kinase catalytic subunit gamma 1 [KO:K00871] [EC:2.7.11.19]
101920095  AVPR1B; arginine vasopressin receptor 1B [KO:K04227]
101920115  PDE1C; phosphodiesterase 1C [KO:K13755] [EC:3.1.4.17]
101920129  FGF22; fibroblast growth factor 22 [KO:K04358]
101920171  FGF23; fibroblast growth factor 23 [KO:K22428]
101920218  NGF; nerve growth factor [KO:K02582]
101920297  NTRK1; neurotrophic receptor tyrosine kinase 1 [KO:K03176] [EC:2.7.10.1]
101920320  FGF5; fibroblast growth factor 5 [KO:K04358]
101920326  PTGER3; prostaglandin E receptor 3 [KO:K04260]
101920333  MST1R; macrophage stimulating 1 receptor [KO:K05100] [EC:2.7.10.1]
101920370  [KO:K04959]
101920400  GRM1; glutamate metabotropic receptor 1 [KO:K04603]
101920533  [KO:K04198]
101920584  KDR; kinase insert domain receptor [KO:K05098] [EC:2.7.10.1]
101920700  PLCD4; phospholipase C delta 4 [KO:K05857] [EC:3.1.4.11]
101920747  FGFR3; fibroblast growth factor receptor 3 [KO:K05094] [EC:2.7.10.1]
101920857  ADRA1B; adrenoceptor alpha 1B [KO:K04136]
101920861  PDGFB; platelet derived growth factor subunit B [KO:K17386]
101920886  PTGFR; prostaglandin F receptor [KO:K04262]
101920927  ITPKA; inositol-trisphosphate 3-kinase A [KO:K00911] [EC:2.7.1.127]
101921272  SPHK1; sphingosine kinase 1 [KO:K04718] [EC:2.7.1.91]
101921528  ADCY8; adenylate cyclase 8 [KO:K08048] [EC:4.6.1.1]
101921567  ADCY3; adenylate cyclase 3 [KO:K08043] [EC:4.6.1.1]
101921590  MET; MET proto-oncogene, receptor tyrosine kinase [KO:K05099] [EC:2.7.10.1]
101921607  GDNF; glial cell derived neurotrophic factor [KO:K05452]
101921612  CACNA1E; calcium voltage-gated channel subunit alpha1 E [KO:K04852]
101921726  NOS2; nitric oxide synthase 2 [KO:K13241] [EC:1.14.13.39]
101921768  ADCY9; adenylate cyclase 9 [KO:K08049] [EC:4.6.1.1]
101921803  PRKACB; protein kinase cAMP-activated catalytic subunit beta [KO:K04345] [EC:2.7.11.11]
101921811  AVPR1A; arginine vasopressin receptor 1A [KO:K04226]
101921826  CCKBR; cholecystokinin B receptor [KO:K04195]
101921871  FGF10; fibroblast growth factor 10 [KO:K04358]
101922032  MYLK2; myosin light chain kinase 2 [KO:K00907] [EC:2.7.11.18]
101922058  CACNA1B; calcium voltage-gated channel subunit alpha1 B [KO:K04849]
101922066  [KO:K00907] [EC:2.7.11.18]
101922071  [KO:K04853]
101922216  RET; ret proto-oncogene [KO:K05126] [EC:2.7.10.1]
101922220  LHCGR; luteinizing hormone/choriogonadotropin receptor [KO:K04248]
101922280  CACNA1H; calcium voltage-gated channel subunit alpha1 H [KO:K04855]
101922302  [KO:K10785]
101922304  MCOLN1; mucolipin-1 [KO:K04992]
101922321  GNAS; GNAS complex locus [KO:K04632]
101922366  PLCB1; phospholipase C beta 1 [KO:K05858] [EC:3.1.4.11]
101922378  FGF7; fibroblast growth factor 7 [KO:K04358]
101922474  FGF1; fibroblast growth factor 1 [KO:K18496]
101922502  MYLK; myosin light chain kinase [KO:K00907] [EC:2.7.11.18]
101922505  PDGFA; platelet derived growth factor subunit A [KO:K04359]
101922526  FLT1; fms related tyrosine kinase 1 [KO:K05096] [EC:2.7.10.1]
101922583  SLC8A1; solute carrier family 8 member A1 [KO:K05849]
101922648  [KO:K04809]
101922673  ATP2B1; ATPase plasma membrane Ca2+ transporting 1 [KO:K05850] [EC:7.2.2.10]
101922702  TACR1; tachykinin receptor 1 [KO:K04222]
101922780  MCOLN2; mucolipin 2 [KO:K04993]
101922782  FGF8; fibroblast growth factor 8 [KO:K04358]
101922950  PDE1A; phosphodiesterase 1A [KO:K13755] [EC:3.1.4.17]
101922956  MCOLN3; mucolipin 3 [KO:K04994]
101923075  ORAI2; ORAI calcium release-activated calcium modulator 2 [KO:K16057]
101923328  [KO:K04150]
101923431  [KO:K04161]
101923556  HTR6; 5-hydroxytryptamine receptor 6 [KO:K04162]
101923570  ADRA1A; adrenoceptor alpha 1A [KO:K04135]
101923629  PPP3R1; protein phosphatase 3 regulatory subunit B, alpha [KO:K06268]
101923649  SLC25A31; solute carrier family 25 member 31 [KO:K05863]
101923673  FGF9; fibroblast growth factor 9 [KO:K04358]
101923678  CHRM5; cholinergic receptor muscarinic 5 [KO:K04133]
101923730  STIM1; stromal interaction molecule 1 [KO:K16059]
101923747  [KO:K02183]
101923748  CAMK2B; calcium/calmodulin dependent protein kinase II beta [KO:K04515] [EC:2.7.11.17]
101923885  CHRM3; cholinergic receptor muscarinic 3 [KO:K04131]
101923890  GNA11; G protein subunit alpha 11 [KO:K04635]
101924046  MCU; mitochondrial calcium uniporter [KO:K20858]
101924192  CASQ1; calsequestrin 1 [KO:K23468]
101924256  PDE1B; phosphodiesterase 1B [KO:K13755] [EC:3.1.4.17]
101924292  P2RX1; purinergic receptor P2X 1 [KO:K05215]
101924493  PHKA2; phosphorylase kinase regulatory subunit alpha 2 [KO:K07190]
101924543  PLCZ1; phospholipase C zeta 1 [KO:K05861] [EC:3.1.4.11]
101924881  ADORA2A; adenosine A2a receptor [KO:K04266]
Compound
C00002  ATP
C00004  NADH
C00076  Calcium cation
C00165  Diacylglycerol
C00575  3',5'-Cyclic AMP
C01245  D-myo-Inositol 1,4,5-trisphosphate
C01330  Sodium cation
C06124  Sphingosine 1-phosphate
C11556  1-Phosphatidyl-1D-myo-inositol 3,5-bisphosphate
C13050  Cyclic ADP-ribose
C13051  Nicotinic acid adenine dinucleotide phosphate
Reference
  Authors
Berridge MJ, Bootman MD, Roderick HL.
  Title
Calcium signalling: dynamics, homeostasis and remodelling.
  Journal
Nat Rev Mol Cell Biol 4:517-29 (2003)
DOI:10.1038/nrm1155
Reference
  Authors
Berridge MJ, Lipp P, Bootman MD.
  Title
The versatility and universality of calcium signalling.
  Journal
Nat Rev Mol Cell Biol 1:11-21 (2000)
DOI:10.1038/35036035
Reference
  Authors
Wang MC, Dolphin A, Kitmitto A.
  Title
L-type voltage-gated calcium channels: understanding function through structure.
  Journal
FEBS Lett 564:245-50 (2004)
DOI:10.1016/S0014-5793(04)00253-4
Reference
  Authors
Ferrier GR, Howlett SE.
  Title
Cardiac excitation-contraction coupling: role of membrane potential in regulation of contraction.
  Journal
Am J Physiol Heart Circ Physiol 280:H1928-44 (2001)
DOI:10.1152/ajpheart.2001.280.5.H1928
Reference
  Authors
Keef KD, Hume JR, Zhong J.
  Title
Regulation of cardiac and smooth muscle Ca(2+) channels (Ca(V)1.2a,b) by protein kinases.
  Journal
Am J Physiol Cell Physiol 281:C1743-56 (2001)
DOI:10.1152/ajpcell.2001.281.6.C1743
Reference
PMID:8125957
  Authors
Hell JW, Appleyard SM, Yokoyama CT, Warner C, Catterall WA.
  Title
Differential phosphorylation of two size forms of the N-type calcium channel alpha 1 subunit which have different COOH termini.
  Journal
J Biol Chem 269:7390-6 (1994)
Reference
  Authors
Yunker AM.
  Title
Modulation and pharmacology of low voltage-activated ("T-Type") calcium channels.
  Journal
J Bioenerg Biomembr 35:577-98 (2003)
DOI:10.1023/B:JOBB.0000008025.65675.37
Reference
PMID:9149541
  Authors
Yakel JL.
  Title
Calcineurin regulation of synaptic function: from ion channels to transmitter release and gene transcription.
  Journal
Trends Pharmacol Sci 18:124-34 (1997)
DOI:10.1016/S0165-6147(97)01046-8
Reference
  Authors
Fukunaga K, Miyamoto E.
  Title
A working model of CaM kinase II activity in hippocampal long-term potentiation and memory.
  Journal
Neurosci Res 38:3-17 (2000)
DOI:10.1016/S0168-0102(00)00139-5
Reference
PMID:9235901
  Authors
Della Rocca GJ, van Biesen T, Daaka Y, Luttrell DK, Luttrell LM, Lefkowitz RJ.
  Title
Ras-dependent mitogen-activated protein kinase activation by G protein-coupled receptors. Convergence of Gi- and Gq-mediated pathways on calcium/calmodulin, Pyk2, and Src kinase.
  Journal
J Biol Chem 272:19125-32 (1997)
DOI:10.1074/jbc.272.31.19125
Reference
PMID:7861177
  Authors
Furuichi T, Mikoshiba K.
  Title
Inositol 1, 4, 5-trisphosphate receptor-mediated Ca2+ signaling in the brain.
  Journal
J Neurochem 64:953-60 (1995)
DOI:10.1046/j.1471-4159.1995.64030953.x
Reference
  Authors
Bruce JI, Straub SV, Yule DI.
  Title
Crosstalk between cAMP and Ca2+ signaling in non-excitable cells.
  Journal
Cell Calcium 34:431-44 (2003)
DOI:10.1016/S0143-4160(03)00150-7
Reference
  Authors
Lee HC, Munshi C, Graeff R.
  Title
Structures and activities of cyclic ADP-ribose, NAADP and their metabolic enzymes.
  Journal
Mol Cell Biochem 193:89-98 (1999)
DOI:10.1007/978-1-4419-8740-2_13
Reference
  Authors
Crompton M.
  Title
Mitochondrial intermembrane junctional complexes and their role in cell death.
  Journal
J Physiol 529 Pt 1:11-21 (2000)
DOI:10.1111/j.1469-7793.2000.00011.x
Reference
  Authors
Grewal SS, York RD, Stork PJ.
  Title
Extracellular-signal-regulated kinase signalling in neurons.
  Journal
Curr Opin Neurobiol 9:544-53 (1999)
DOI:10.1016/S0959-4388(99)00010-0
Reference
  Authors
Trushin SA, Pennington KN, Carmona EM, Asin S, Savoy DN, Billadeau DD, Paya CV.
  Title
Protein kinase Calpha (PKCalpha) acts upstream of PKCtheta to activate IkappaB kinase and NF-kappaB in T lymphocytes.
  Journal
Mol Cell Biol 23:7068-81 (2003)
DOI:10.1128/MCB.23.19.7068-7081.2003
Reference
  Authors
Hutchins JR, Dikovskaya D, Clarke PR.
  Title
Regulation of Cdc2/cyclin B activation in Xenopus egg extracts via inhibitory phosphorylation of Cdc25C phosphatase by Ca(2+)/calmodulin-dependent protein [corrected] kinase II.
  Journal
Mol Biol Cell 14:4003-14 (2003)
DOI:10.1091/mbc.E03-02-0061
Reference
  Authors
Tornquist K
  Title
Sphingosine 1-phosphate, sphingosine kinase and autocrine calcium signalling in thyroid cells.
  Journal
Acta Physiol (Oxf) 204:151-7 (2012)
DOI:10.1111/j.1748-1716.2011.02265.x
Reference
  Authors
Feske S
  Title
Immunodeficiency due to defects in store-operated calcium entry.
  Journal
Ann N Y Acad Sci 1238:74-90 (2011)
DOI:10.1111/j.1749-6632.2011.06240.x
Reference
  Authors
Giachini FR, Lima VV, Hannan JL, Carneiro FS, Webb RC, Tostes RC
  Title
STIM1/Orai1-mediated store-operated Ca2+ entry: the tip of the iceberg.
  Journal
Braz J Med Biol Res 44:1080-7 (2011)
DOI:10.1590/S0100-879X2011007500133
Reference
  Authors
Baba Y, Kurosaki T
  Title
[Regulation of store-operated calcium entry by STIM1].
  Journal
Seikagaku 80:1123-8 (2008)
Reference
  Authors
Galione A, Evans AM, Ma J, Parrington J, Arredouani A, Cheng X, Zhu MX
  Title
The acid test: the discovery of two-pore channels (TPCs) as NAADP-gated endolysosomal Ca(2+) release channels.
  Journal
Pflugers Arch 458:869-76 (2009)
DOI:10.1007/s00424-009-0682-y
Reference
  Authors
Beard NA, Wei L, Dulhunty AF
  Title
Ca(2+) signaling in striated muscle: the elusive roles of triadin, junctin, and calsequestrin.
  Journal
Eur Biophys J 39:27-36 (2009)
DOI:10.1007/s00249-009-0449-6
Reference
  Authors
Marty I
  Title
Triadin regulation of the ryanodine receptor complex.
  Journal
J Physiol 593:3261-6 (2015)
DOI:10.1113/jphysiol.2014.281147
Reference
  Authors
Arvanitis DA, Vafiadaki E, Sanoudou D, Kranias EG
  Title
Histidine-rich calcium binding protein: the new regulator of sarcoplasmic reticulum calcium cycling.
  Journal
J Mol Cell Cardiol 50:43-9 (2011)
DOI:10.1016/j.yjmcc.2010.08.021
Related
pathway
fpg04010  MAPK signaling pathway
fpg04070  Phosphatidylinositol signaling system
fpg04210  Apoptosis
KO pathway
ko04020   

DBGET integrated database retrieval system